FDA Approvals FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma
Conference Highlights Lung Cancer Screening at VA Northern California: Real-World Insights Into High-Risk Lung-RADS 4 Nodules
FDA Approvals FDA Approves Lurbinectedin and Atezolizumab Combination for Extensive-Stage Small Cell Lung Cancer
